EUVIMEDEUVIMED entdecken
ZwillingsstudieOpen Access

Serum Metabolomics Reveals Potential Differences in Gut Microbiota–Associated Metabolites in Twins Discordant for Type 1 Diabetes

Elizabeth R Flammer, Michael W Christopher, Esabella R Powers, Hali Broncucia, Andrea K Steck, Stephen E Gitelman, Timothy J Garrett iD, Heba M Ismail iD

Diabetes · 2025

DOI: 10.2337/db25-0156 ↗

Kurz gefasst

Zwillingsstudie in der Zeitschrift Diabetes, 2025. Verfasst von Elizabeth R Flammer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Liberal Arts and Sciences, University of Florida, Gainesville, FL. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Gastrointestinal Microbiome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We investigated serum metabolites in monozygotic (MZ) and dizygotic (DZ) twins discordant for type 1 diabetes (T1D) to explore potential environmental factors, with a focus on differences in gut microbiota–associated metabolites that may influence T1D. Serum samples from 39 twins discordant for T1D were analyzed using a semi-targeted metabolomics approach via liquid chromatography–high-resolution tandem mass spectrometry. Statistical analyses identified significant metabolites (P < 0.1) within three groups: all twins (combined group [All]), MZ twins, and DZ twins. Thirteen metabolites exhibited significant differences between individuals with T1D and those without T1D. Across all groups, 3-indoxyl sulfate and 5-hydroxyindole were significantly reduced in individuals with T1D. Carnitine was reduced, and threonine, muramic acid, and 2-oxobutyric acid were significantly elevated in both All and MZ groups. Allantoin was significantly reduced and 3-methylhistidine was significantly elevated in All and DZ groups. These findings suggest metabolite dysregulation associated with gut dysbiosis was observed. However, further validation of our findings in a larger cohort is needed. Article Highlights We believed this cohort of twins discordant for type 1 diabetes (T1D) would allow for control over genetic variability to examine environmental factors. We aimed to identify differences in microbial and microbiota-associated metabolites in twins discordant for T1D to examine the effect of the gut microbiome on T1D. Thirteen metabolites were identified as significantly different. Our results show dysregulation of several microbial metabolites in twin pairs, suggesting the role of the gut microbiome in T1D pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Gastrointestinal MicrobiomeAdolescentAdultChildFemaleHumansMaleYoung AdultDysbiosisMetabolomeMetabolomicsTwins, DizygoticTwins, Monozygotic

Autor:innen und Institutionen

  • Department of Chemistry, College of Liberal Arts and Sciences, University of Florida, Gainesville, FL.
  • Barbara Davis Center for Childhood Diabetes, School of Medicine, University of Colorado, Aurora, CO.
  • Department of Pediatrics, University of California San Francisco, San Francisco, CA.
  • Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL.
  • Department of Pediatrics, School of Medicine, Indiana University, Indianapolis, IN.

ORCID-Profile: Timothy J Garrett, Heba M Ismail

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health

Zitieren

APA

Flammer, E. R., Christopher, M. W., Powers, E. R., Broncucia, H., Steck, A. K., Gitelman, S. E., Garrett, T. J., & Ismail, H. M. (2025). Serum Metabolomics Reveals Potential Differences in Gut Microbiota–Associated Metabolites in Twins Discordant for Type 1 Diabetes. Diabetes. https://doi.org/10.2337/db25-0156

Vancouver

Flammer ER, Christopher MW, Powers ER, Broncucia H, Steck AK, Gitelman SE, et al. Serum Metabolomics Reveals Potential Differences in Gut Microbiota–Associated Metabolites in Twins Discordant for Type 1 Diabetes. Diabetes. 2025. doi:10.2337/db25-0156

BibTeX
@article{Flammer2025,
  author = {Flammer, Elizabeth R and Christopher, Michael W and Powers, Esabella R and Broncucia, Hali and Steck, Andrea K and Gitelman, Stephen E and Garrett, Timothy J and Ismail, Heba M},
  title = {Serum Metabolomics Reveals Potential Differences in Gut Microbiota–Associated Metabolites in Twins Discordant for Type 1 Diabetes},
  journal = {Diabetes},
  year = {2025},
  doi = {10.2337/db25-0156}
}
Kostenlos starten →